Irritable Bowel Syndrome (IBS) Market report focuses on the major drivers and restraints for the key players. The Irritable Bowel Syndrome (IBS) Market research report is a professional and in-depth study on the current state of the Irritable Bowel Syndrome (IBS) Industry.
Irritable Bowel Syndrome (IBS) market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Request for a Sample PDF of Report at https://www.360researchreports.com/enquiry/request-sample/13535683
The Irritable Bowel Syndrome (IBS) market report includes the forecasts, Analysis, and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.
Major Key Players are Analysed in the Irritable Bowel Syndrome (IBS) Market Report such as:
- Valeant Pharmaceuticals
- Sucampo Pharmaceuticals
- McNeil Consumer Healthcare
- Sebela Pharmaceuticals
- Astellas Pharmaceuticals
- IM HealthScience
Irritable Bowel Syndrome (IBS) Market: Product Segment Analysis:
- IBS-D Drug
- IBS-C Drug
Irritable Bowel Syndrome (IBS) Market Scope: –
This report focuses on the Irritable Bowel Syndrome (IBS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.The worldwide market for Irritable Bowel Syndrome (IBS) is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 6530 million US$ in 2023, from 2640 million US$ in 2017
Buy this report (Price 3480 USD for a single-user license) – https://www.360researchreports.com/purchase/13535683
Market Segment by Regions, this Irritable Bowel Syndrome (IBS) market report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Irritable Bowel Syndrome (IBS) Market from 2014 to 2024 (forecast), like:
- Europe Union
- southeast Asia
Fill the Pre-Order Enquiry form for the report – https://www.360researchreports.com/enquiry/pre-order-enquiry/13535683
This Irritable Bowel Syndrome (IBS) Market report also takes into account the past price of 2014-2015 and the future price of 2019-2024 as per the supply-demand relation along with perspectives and Irritable Bowel Syndrome (IBS) market forecasts. Additionally, the Irritable Bowel Syndrome (IBS) Market report also discusses the data on deals (distributors) and buyers, providing a holistic insight into the supply chain and sales details of Irritable Bowel Syndrome (IBS) Market.
Irritable Bowel Syndrome (IBS) Market: Application Segment Analysis:
To sum it up, the report concludes with an all-inclusive research result on the Market chain of Irritable Bowel Syndrome (IBS) Market facilitating the market participants in making well-informed strategic decisions.
Major Table of Contents in Report:
- Irritable Bowel Syndrome (IBS) Market Competition Landscape
- World Irritable Bowel Syndrome (IBS) Market share
- Industry Supply Chain Analysis
- World Irritable Bowel Syndrome (IBS) Market Forecast through 2024
- Globalisation & Trade
Browse Irritable Bowel Syndrome (IBS) Market related details of TOC @ https://www.360researchreports.com/TOC/13535683,TOC
360 Research Report is a credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed to optimizing your business. The reports we provide are based on research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Name: Ajay More
Email: [email protected]
Organization: 360 Research Report